Nabriva Therapeutics plc (NBRV) |
|
2.39 -0.19 (-7.36%)
|
05-20 16:00 |
|
Open: |
2.51 |
Pre. Close: |
2.58 |
|
High:
|
2.64 |
Low:
|
2.365 |
|
Volume:
|
961,113 |
Market Cap:
|
167M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.646 - 2.662 |
2.662 - 2.673 |
|
Low:
|
2.335 - 2.355 |
2.355 - 2.369 |
|
Close:
|
2.365 - 2.393 |
2.393 - 2.414 |
|
|
|
Technical analysis |
as of: 2019-05-20 4:29:03 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 3.12  One year: 3.59 |
| Support: |
Support1: 2.02 Support2: 1.68 |
| Resistance: |
Resistance1: 2.67 Resistance2: 3.07 |
| Pivot: |
2.47 |
| Moving Average: |
MA(5): 2.62 MA(20): 2.56
MA(100): 2.31  MA(250): 2.64 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.04 |
| Stochastic oscillator: |
%K(14,3): 51.43 %D(3): 59.79 |
| RSI: |
RSI(14): 43.80 |
| 52-week: |
High: 4.89 Low: 1.12 Change(%): -47.2 |
| Average Vol(K): |
3-Month: 142338 10-Days: 94051 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.NBRV has closed above bottom band by 42.6%. Bollinger Bands are 36.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 01 May 2019 20:24:20 Z
Health Care Sector Update for 05/01/2019: NBIX,NBRV,TDOC,HCSG
Wed, 01 May 2019 18:24:24 Z
Health Care Sector Update for 05/01/2019: NBRV,TDOC,HCSG
Wed, 01 May 2019 13:48:56 Z
Health Care Sector Update for 05/01/2019: NBRV, TNDM, HUM, JNJ, PFE, ABT, MRK, AMGN
Wed, 01 May 2019 12:58:47 Z
Pre-Market Most Active for May 1, 2019 : AMD, AAPL, CVS, NBRV, SQQQ, PINS, QQQ, AMRN, TWLO, GE, QD, GSK
Thu, 04 Apr 2019 15:14:29 Z
Nabriva Therapeutics (NBRV) in Focus: Stock Moves 7.5% Higher
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
72.56 |
| Shares Float (M) |
72.26 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
52.90 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.560 |
|
EPS Est. Current Year
|
-2.290 |
|
EPS Est. Next Year
|
-1.990 |
|
EPS Est. Next Quarter
|
-0.500 |
|
Forward EPS
|
-1.988 |
|
Book Value (p.s.)
|
3.270 |
|
PEG Ratio
|
-0.02 |
|
Profit Margin
|
|
|
Operating Margin
|
-2329.49 |
|
Return on Assets (ttm)
|
-124.5 |
|
Return on Equity (ttm)
|
-173.0 |
|
Qtrly Rev. Growth
|
-77.4 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-77.01 |
|
Levered Free Cash Flow (M)
|
-43.73 |
Stock Valuations |
|
P/E
|
-1.53 |
|
P/E Growth Ratio
|
-0.07 |
|
P/BV
|
0.73 |
|
P/S
|
3331660032.00 |
|
P/CF
|
-2.25 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2017-06-26 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
